Polite Tumor
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2017 | 62,225 | 0 | 62,225 | — | — |
| 2018 | 170,938 | 31,542 | 139,396 | 76.7 | — |
| 2019 | 119,566 | 165,757 | −46,191 | 11.3 | — |
| 2020 | 156,741 | 95,632 | 61,109 | 27.2 | — |
| 2021 | 166,587 | 73,494 | 93,093 | 50.6 | — |
| 2022 | 269,475 | 151,693 | 117,782 | 33.8 | 0% |
| 2023 | 269,306 | 216,818 | 52,488 | 26.6 | 0% |
In its most recent public year (2023), this organization brought in $52,488 more than it spent. Its reserves stood at about 26.6 months of spending. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Polite Tumor's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works